World Stroke Day (WSD) serves as a vital reminder of the importance of stroke awareness and understanding its lasting impact. At MMRI, researchers are committed to discovering treatments and potential cures to help people live happier and healthier lives. A stroke occurs when the normal flow of blood to the brain is interrupted, cutting off oxygen and nutrients and leading brain cells to die within minutes.

At MMRI, the Kessinger lab studies venous thromboembolism, a condition that has the potential to lead to serious side effects such as stroke. Venous thromboembolism (VTE) refers to a blood clot that starts in a vein (AHA). Using intravital confocal microscopy of large vein thrombosis, Dr. Kessinger has shown the ability to capture high-resolution spatial maps of the venous thrombosis inflammation and structure that will help identify potential treatments.

World Stroke Day is an important opportunity to reflect on the impact of stroke and the ongoing need for research and awareness. At MMRI, Dr. Kessinger and his team are dedicated to advancing innovative solutions in nanomedicine and molecular imaging to better prevent and treat venous thromboembolism and stroke. To learn more about Dr. Kessinger’s work and his commitment to improving patient outcomes, visit https://www.mmri.edu/kessinger-lab/.

Did you know? Dr. Chase Kessinger contributed to this major publication regarding cardiomyopathies that are known to increase risk of strokes: https://pubmed.ncbi.nlm.nih.gov/40694612/.